Giovanni Battista Migliori Selected Research

Antitubercular Agents

4/2018	Epidemiological aspects, clinical manifestations, and prevention of pediatric tuberculosis from the perspective of the End TB Strategy.
6/2015	Facing multi-drug resistant tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Battista Migliori Research Topics

Disease

36	Tuberculosis (Tuberculoses) 05/2023 - 07/2005
28	Extensively Drug-Resistant Tuberculosis 12/2022 - 10/2009
23	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 11/2022 - 12/2012
7	COVID-19 11/2023 - 01/2020
6	Infections 11/2022 - 04/2016
4	Latent Tuberculosis 10/2022 - 01/2018
3	HIV Infections (HIV Infection) 10/2016 - 01/2015
2	Pulmonary Tuberculosis 01/2024 - 01/2019
2	Coinfection 05/2023 - 09/2013
2	Lung Diseases (Lung Disease) 01/2022 - 03/2016
2	Asthma (Bronchial Asthma) 01/2022 - 12/2020
2	Lung Injury 01/2018 - 04/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2024
1	Inflammation (Inflammations) 01/2022
1	Malnutrition (Nutritional Deficiencies) 03/2020
1	Critical Illness (Critically Ill) 01/2020
1	Bacterial Infections (Bacterial Infection) 04/2019
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 10/2017
1	Tuberculoma 07/2016
1	Pleural Empyema (Pyothorax) 07/2016
1	Meningeal Tuberculosis (Tuberculous Meningitis) 02/2016
1	Tuberculous Pericarditis 02/2016
1	Avitaminosis (Vitamin Deficiency) 02/2016
1	Necrosis 12/2015
1	Silicosis 12/2015
1	Noncommunicable Diseases 10/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2012

Drug/Important Bio-Agent (IBA)

22	bedaquiline (R207910)IBA 11/2022 - 01/2014
20	OPC-67683IBA 11/2022 - 09/2014
10	Linezolid (Zyvox)FDA Link 11/2022 - 10/2009
10	Rifampin (Rifampicin)FDA LinkGeneric 11/2022 - 09/2010
7	Isoniazid (Ftivazide)FDA LinkGeneric 11/2022 - 09/2010
6	Meropenem (Merrem)FDA LinkGeneric 01/2018 - 06/2013
5	Biomarkers (Surrogate Marker)IBA 03/2020 - 04/2016
5	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 05/2016 - 06/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 02/2016
4	AntigensIBA 05/2023 - 01/2008
4	FluoroquinolonesIBA 11/2022 - 10/2012
3	Tuberculin (PPD)IBA 11/2022 - 01/2008
3	Interferon-gamma (Interferon, gamma)IBA 10/2022 - 06/2019
3	Imipenem FDA Link 05/2016 - 01/2016
2	Oxygen (Dioxygen)IBA 11/2023 - 09/2016
2	Antitubercular AgentsIBA 04/2018 - 06/2015
2	pretomanidIBA 01/2018 - 05/2015
2	Clofazimine (Lamprene)FDA Link 03/2017 - 11/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 01/2016
2	Ertapenem (Invanz)FDA Link 03/2016 - 01/2016
2	VaccinesIBA 10/2015 - 03/2015
2	Moxifloxacin (Avelox)FDA Link 03/2015 - 09/2006
1	Bronchodilator Agents (Bronchodilators)IBA 05/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2023
1	CytokinesIBA 05/2023
1	ChemokinesIBA 05/2023
1	InterleukinsIBA 05/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2023
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 05/2023
1	mesoglycanIBA 12/2022
1	BCG Vaccine FDA Link 09/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	MacrolidesIBA 01/2022
1	Amikacin (A.M.K)FDA LinkGeneric 01/2022
1	Monoclonal AntibodiesIBA 07/2021
1	COVID-19 VaccinesIBA 07/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Proteins (Proteins, Gene)FDA Link 03/2020
1	nirmatrelvir and ritonavir drug combinationIBA 01/2020
1	GS-621763IBA 01/2020
1	favipiravirIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2017
1	GasesIBA 09/2016
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2016
1	Vitamin B 6IBA 02/2016
1	Nucleic AcidsIBA 10/2015
1	Volatile Organic CompoundsIBA 10/2015
1	Gatifloxacin (Zymar)FDA Link 03/2015
1	SolutionsIBA 01/2015
1	Ethambutol (Myambutol)FDA LinkGeneric 09/2010
1	Pyrazinamide FDA LinkGeneric 09/2010
1	Peptides (Polypeptides)IBA 01/2008
1	GoldIBA 01/2008
1	NucleotidesIBA 07/2005
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 07/2005

Therapy/Procedure

17	Therapeutics 05/2024 - 03/2015
6	Duration of Therapy 01/2020 - 03/2015
3	Drug Therapy (Chemotherapy) 11/2022 - 07/2016
2	Critical Care (Surgical Intensive Care) 04/2019 - 01/2019
2	Art Therapy 01/2015 - 01/2012
1	Aftercare (After-Treatment) 01/2024
1	Combined Modality Therapy 12/2020
1	Continuity of Patient Care 11/2020
1	Operative Surgical Procedures 03/2020
1	Nutritional Support (Artificial Feeding) 04/2019
1	Transplantation 12/2015